FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Anne Goodeve

Research Profile

Disorders

Chemicals & Drugs

Physiology

Procedures

Concepts & Ideas

Gene Frequency

Genes & Molecular Sequences

Alleles

Co-author Network

Publications

TOP 3
J C J Eikenboom; Augusto B Federici; Anne C Goodeve; Jenny Goudemand; Ian R Peake; Francesco Rodeghiero; Reinhard Schneppenheim; Javier Batlle; Ulrich Budde; Maria Teresa Canciani; Giancarlo Castaman; Richard J Dirven
VWF propeptide and ratios between VWF, VWF propeptide, and FVIII in the characterization of type 1 von Willebrand disease.
Claudia Pamela Radic; Liliana C Rossetti; Miguel Martín Abelleyro; Miguel Candela; Miguel de Tezanos Pinto; Anne C Goodeve; Irene Larripa; Raúl Pérez Bianco; Carlos De Brasi
Assessment of the F9 genotype-specific FIX inhibitor risks and characterisation of 10 novel severe F9 defects in the first molecular series of Argentinian patients with haemophilia B.
Peter C Cooper; Anne C Goodeve; Nicholas J Beauchamp
Quality in molecular biology testing for inherited thrombophilia disorders.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Anne Goodeve (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: J C J Eikenboom; Augusto B Federici; Anne C Goodeve; Jenny Goudemand; Ian R Peake; Francesco Rodeghiero; Reinhard Schneppenheim; Javier Batlle; Ulrich Budde; Maria Teresa Canciani; Giancarlo Castaman; Richard J Dirven
VWF propeptide and ratios between VWF, VWF propeptide, and FVIII in the characterization of type 1 von Willebrand disease.
Blood 2013;121(12):2336-9.
2013: Claudia Pamela Radic; Liliana C Rossetti; Miguel Martín Abelleyro; Miguel Candela; Miguel de Tezanos Pinto; Anne C Goodeve; Irene Larripa; Raúl Pérez Bianco; Carlos De Brasi
Assessment of the F9 genotype-specific FIX inhibitor risks and characterisation of 10 novel severe F9 defects in the first molecular series of Argentinian patients with haemophilia B.
Thrombosis and haemostasis 2013;109(1):24-33.
2012: Peter C Cooper; Anne C Goodeve; Nicholas J Beauchamp
Quality in molecular biology testing for inherited thrombophilia disorders.
Seminars in thrombosis and hemostasis 2012;38(6):600-12.
2011: Annette E Bowyer; Anne C Goodeve; Steve Kitchen; Ri Liesner; Andrew D Mumford; Mike Makris
p.Tyr365Cys change in factor VIII: haemophilia A, but not as we know it.
British journal of haematology 2011;154(5):618-25.
2011: Steven Keeney; Peter Collins; Anthony Cumming; Anne C Goodeve; John Pasi
Diagnosis and management of von Willebrand disease in the United Kingdom.
Seminars in thrombosis and hemostasis 2011;37(5):488-94.
2011: Daniel J Hampshire; Anne C Goodeve
The international society on thrombosis and haematosis von Willebrand disease database: an update.
Seminars in thrombosis and hemostasis 2011;37(5):470-9.
2011: Daniel J Hampshire; Anne C Goodeve
The molecular basis of von Willebrand disease: the under investigated, the unexpected and the overlooked.
Haematologica 2011;96(6):798-800.
2011: Paula D James; Anne C Goodeve
von Willebrand disease.
Genetics in medicine : official journal of the American College of Medical Genetics 2011;13(5):365-76.
2011: Anne C Goodeve; P H Reitsma; J H McVey
Nomenclature of genetic variants in hemostasis.
Journal of thrombosis and haemostasis : JTH 2011;9(4):852-5.
2010: Daniel J Hampshire; George J Burghel; Jenny Goudemand; Laura C S Bouvet; Jeroen C J Eikenboom; Reinhard Schneppenheim; Ulrich Budde; Ian R Peake; Anne C Goodeve
Polymorphic variation within the VWF gene contributes to the failure to detect mutations in patients historically diagnosed with type 1 von Willebrand disease from the MCMDM-1VWD cohort.
Haematologica 2010;95(12):2163-5.
2010: Giancarlo Castaman; Alberto Tosetto; Anne C Goodeve; Augusto B Federici; Stefan Lethagen; Ulrich Budde; Javier Batlle; Dominique Meyer; Claudine Mazurier; Jenny Goudemand; Jeroen Eikenboom; Reinhard Schneppenheim; Jørgen Ingerslev; David Habart; Frank Hill; Ian R Peake; Francesco Rodeghiero
The impact of bleeding history, von Willebrand factor and PFA-100(®) on the diagnosis of type 1 von Willebrand disease: results from the European study MCMDM-1VWD.
British journal of haematology 2010;151(3):245-51.
2010: N Hickson; D Hampshire; Peter R Winship; Jenny Goudemand; Reinhard Schneppenheim; Ulrich Budde; Giancarlo Castaman; Francesco Rodeghiero; Augusto B Federici; P James; Ian R Peake; J C J Eikenboom; Anne C Goodeve
von Willebrand factor variant p.Arg924Gln marks an allele associated with reduced von Willebrand factor and factor VIII levels.
Journal of thrombosis and haemostasis : JTH 2010;8(9):1986-93.
2010: Anne C Goodeve; S Rosén; B Verbruggen
Haemophilia A and von Willebrand's disease.
Haemophilia : the official journal of the World Federation of Hemophilia 2010;16 Suppl 5():79-84.
2010: Anne C Goodeve
Vicenza deciphered: modeling the von Willebrand disease enigma: commentary on accelerated clearance alone explains ultralarge multimers in VWD Vicenza.
Journal of thrombosis and haemostasis : JTH 2010;8(6):1271-2.
2010: Daniel C Gilby; Hye-Youn Sung; Peter R Winship; Anne C Goodeve; John T Reilly; Endre Kiss-Toth
Tribbles-1 and -2 are tumour suppressors, down-regulated in human acute myeloid leukaemia.
Immunology letters 2010;130(1-2):115-24.
2010: Anne C Goodeve
The genetic basis of von Willebrand disease.
Blood reviews 2010;24(3):123-34.
2010: Ian R Peake; Anne C Goodeve
Genetic testing for von Willebrand disease: the case for.
Journal of thrombosis and haemostasis : JTH 2010;8(1):13-6.
2009: J C J Eikenboom; L Hilbert; A S Ribba; A Hommais; David Habart; S Messenger; A Al-Buhairan; A Guilliatt; W Lester; Claudine Mazurier; Dominique Meyer; Edith Fressinaud; Ulrich Budde; K Will; Reinhard Schneppenheim; T Obser; O Marggraf; E Eckert; Giancarlo Castaman; Francesco Rodeghiero; Augusto B Federici; Javier Batlle; Jenny Goudemand; Jørgen Ingerslev; Stefan Lethagen; Frank Hill; Ian R Peake; Anne C Goodeve
Expression of 14 von Willebrand factor mutations identified in patients with type 1 von Willebrand disease from the MCMDM-1VWD study.
Journal of thrombosis and haemostasis : JTH 2009;7(8):1304-12.
2009: Anne C Goodeve
When 1 plus 1 equals 3 in VWD.
Blood 2009;114(5):933-4.
2009: Martina E Daly; Ban B Dawood; William A Lester; Ian R Peake; Francesco Rodeghiero; Anne C Goodeve; Michael Makris; Jonathan T Wilde; Andrew D Mumford; Stephen P Watson; Stuart J Mundell
Identification and characterization of a novel P2Y 12 variant in a patient diagnosed with type 1 von Willebrand disease in the European MCMDM-1VWD study.
Blood 2009;113(17):4110-3.
2008: Nasios Fourouclas; Juan Li; Daniel C Gilby; Peter J Campbell; Philip A Beer; Elaine M Boyd; Anne C Goodeve; David Bareford; Claire N Harrison; John T Reilly; Anthony R Green; Anthony J Bench
Methylation of the suppressor of cytokine signaling 3 gene (SOCS3) in myeloproliferative disorders.
Haematologica 2008;93(11):1635-44.
2008: Steven Keeney; D Bowen; Anthony M Cumming; Said M Enayat; Anne C Goodeve; M Hill
The molecular analysis of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organisation Haemophilia Genetics Laboratory Network.
Haemophilia : the official journal of the World Federation of Hemophilia 2008;14(5):1099-111.
2007: Anne C Goodeve
Genetics of type 1 von Willebrand disease.
Current opinion in hematology 2007;14(5):444-9.
2007: Anne C Goodeve
Enhanced carrier and prenatal diagnosis in the Italian haemophilia B population.
Blood transfusion = Trasfusione del sangue 2007;5(3):117-9.
2007: Ian R Peake; Anne C Goodeve
Type 1 von Willebrand disease.
Journal of thrombosis and haemostasis : JTH 2007;5 Suppl 1():7-11.
2007: Liliana C Rossetti; Claudia Pamela Radic; Miguel Candela; Raúl Pérez Bianco; Miguel de Tezanos Pinto; Anne C Goodeve; Irene Larripa; Carlos De Brasi
Sixteen novel hemophilia A causative mutations in the first Argentinian series of severe molecular defects.
Haematologica 2007;92(6):842-5.
2007: Mohammad Hashemi Soteh; Ian R Peake; Luke Marsden; John Anson; Javier Batlle; Dominique Meyer; Edith Fressinaud; Claudine Mazurier; Jenny Goudemand; J C J Eikenboom; Anne C Goodeve
Mutational analysis of the von Willebrand factor gene in type 1 von Willebrand disease using conformation sensitive gel electrophoresis: a comparison of fluorescent and manual techniques.
Haematologica 2007;92(4):550-3.
2007: Alberto Tosetto; Francesco Rodeghiero; Giancarlo Castaman; M Bernardi; K Bertoncello; Anne C Goodeve; Augusto B Federici; Javier Batlle; Dominique Meyer; Claudine Mazurier; Jenny Goudemand; J C J Eikenboom; Reinhard Schneppenheim; Ulrich Budde; Jørgen Ingerslev; Zdena Vorlova; David Habart; Lars Holmberg; Stefan Lethagen; John Pasi; Frank Hill; Ian R Peake
Impact of plasma von Willebrand factor levels in the diagnosis of type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1VWD).
Journal of thrombosis and haemostasis : JTH 2007;5(4):715-21.
2007: Y Sorour; S Heppinstall; N Porter; Gill A Wilson; Anne C Goodeve; D Rees; J Wright
Is routine molecular screening for common alpha-thalassaemia deletions necessary as part of an antenatal screening programme?
Journal of medical screening 2007;14(2):60-1.
2007: Anne C Goodeve; J C J Eikenboom; Giancarlo Castaman; Francesco Rodeghiero; Augusto B Federici; Javier Batlle; Dominique Meyer; Claudine Mazurier; Jenny Goudemand; Reinhard Schneppenheim; Ulrich Budde; Jørgen Ingerslev; David Habart; Zdena Vorlova; Lars Holmberg; Stefan Lethagen; John Pasi; Frank Hill; Mohammad Hashemi Soteh; Luciano Baronciani; Christer Hallden; Andrea M Guilliatt; William A Lester; Ian R Peake
Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD).
Blood 2007;109(1):112-21.
2006: David J Perry; Anne C Goodeve; Marian Hill; Ian Jennings; Steve Kitchen; Isobel Walker
The UK National External Quality Assessment Scheme (UK NEQAS) for molecular genetic testing in haemophilia.
Thrombosis and haemostasis 2006;96(5):597-601.
2006: J C J Eikenboom; Vincent Van Marion; H Putter; Anne C Goodeve; Francesco Rodeghiero; Giancarlo Castaman; Augusto B Federici; Javier Batlle; Dominique Meyer; Claudine Mazurier; Jenny Goudemand; Reinhard Schneppenheim; Ulrich Budde; Jørgen Ingerslev; Zdena Vorlova; David Habart; Lars Holmberg; Stefan Lethagen; John Pasi; Frank Hill; Ian R Peake
Linkage analysis in families diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 VWD.
Journal of thrombosis and haemostasis : JTH 2006;4(4):774-82.
2006: Alberto Tosetto; Francesco Rodeghiero; Giancarlo Castaman; Anne C Goodeve; Augusto B Federici; Javier Batlle; Dominique Meyer; Edith Fressinaud; Claudine Mazurier; Jenny Goudemand; J C J Eikenboom; Reinhard Schneppenheim; Ulrich Budde; Jørgen Ingerslev; Zdena Vorlova; David Habart; Lars Holmberg; Stefan Lethagen; John Pasi; Frank Hill; Ian R Peake
A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD).
Journal of thrombosis and haemostasis : JTH 2006;4(4):766-73.
2005: Muhammad Farid Johan; Anne C Goodeve; David T Bowen; Marion E Frew; John T Reilly
JAK2 V617F Mutation is uncommon in chronic myelomonocytic leukaemia.
British journal of haematology 2005;130(6):968.
2005: Steven Keeney; M Mitchell; Anne C Goodeve
The molecular analysis of haemophilia A: a guideline from the UK haemophilia centre doctors' organization haemophilia genetics laboratory network.
Haemophilia : the official journal of the World Federation of Hemophilia 2005;11(4):387-97.
2005: Muhammad Farid Johan; David T Bowen; Marion E Frew; Anne C Goodeve; John T Reilly
Aberrant methylation of the negative regulators RASSFIA, SHP-1 and SOCS-1 in myelodysplastic syndromes and acute myeloid leukaemia.
British journal of haematology 2005;129(1):60-5.
2004: Liliana C Rossetti; Anne C Goodeve; Irene Larripa; Carlos De Brasi
Homeologous recombination between AluSx-sequences as a cause of hemophilia.
Human mutation 2004;24(5):440.
2004: Liliana C Rossetti; Miguel Candela; Raúl Pérez Bianco; Miguel de Tezanos Pinto; Andrea Western; Anne C Goodeve; Irene Larripa; Carlos De Brasi
Analysis of factor VIII gene intron 1 inversion in Argentinian families with severe haemophilia A and a review of the literature.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2004;15(7):569-72.
2004: Muhammad Farid Johan; Anne C Goodeve; John T Reilly
Activating loop mutations in the PDGFR alpha and beta genes are rare in core binding factor acute myeloid leukaemia.
British journal of haematology 2004;127(1):123-4.
2004: Muhammad Farid Johan; David T Bowen; Marion E Frew; Anne C Goodeve; Gill A Wilson; Ian R Peake; John T Reilly
Mutations in PTPN11 are uncommon in adult myelodysplastic syndromes and acute myeloid leukaemia.
British journal of haematology 2004;124(6):843-4.
2004: Peter J M Valk; David T Bowen; Marion E Frew; Anne C Goodeve; Bob Löwenberg; John T Reilly
Second hit mutations in the RTK/RAS signaling pathway in acute myeloid leukemia with inv(16).
Haematologica 2004;89(1):106.
2003: Faisel M Abu-Duhier; Anne C Goodeve; Gill A Wilson; Ian R Peake; John T Reilly
c-FMS mutational analysis in acute myeloid leukaemia.
British journal of haematology 2003;123(4):749-50.
2003: Gregoire Michaux; Lindsay Hewlett; Sarah L Messenger; Anne C Goodeve; Ian R Peake; Martina E Daly; Daniel F Cutler
Analysis of intracellular storage and regulated secretion of 3 von Willebrand disease-causing variants of von Willebrand factor.
Blood 2003;102(7):2452-8.
2003: Anne C Goodeve
The incidence of inhibitor development according to specific mutations--and treatment?
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2003;14 Suppl 1():S17-21.
2003: Rory S Care; Peter J M Valk; Anne C Goodeve; Faisel M Abu-Duhier; Wendy M C Geertsma-Kleinekoort; Gill A Wilson; Mamdooh A Gari; Ian R Peake; Bob Löwenberg; John T Reilly
Incidence and prognosis of c-KIT and FLT3 mutations in core binding factor (CBF) acute myeloid leukaemias.
British journal of haematology 2003;121(5):775-7.
2003: Anne C Goodeve; Ian R Peake
The molecular basis of hemophilia A: genotype-phenotype relationships and inhibitor development.
Seminars in thrombosis and hemostasis 2003;29(1):23-30.
2003: Faisel M Abu-Duhier; Anne C Goodeve; Rory S Care; Mamdooh A Gari; Gill A Wilson; Ian R Peake; John T Reilly
Mutational analysis of class III receptor tyrosine kinases (C-KIT, C-FMS, FLT3) in idiopathic myelofibrosis.
British journal of haematology 2003;120(3):464-70.
2002: Faisel M Abu-Duhier; Anne C Goodeve; Gill A Wilson; Rory S Carr; Ian R Peake; John T Reilly
FLT3 internal tandem duplication mutations are rare in agnogenic myeloid metaplasia.
Blood 2002;100(1):364.
2002: Ian J Williams; Anne C Goodeve
Conformation-sensitive gel electrophoresis.
Methods in molecular biology (Clifton, N.J.) 2002;187():137-50.
2001: G Wilson; P Forrest; S Heppinstall; B N Green; Anne C Goodeve; Ian R Peake; John T Reilly; N Porter; D C Rees
A second case of Hb Renert [beta133(H11)Val --> Ala].
Hemoglobin 2001;25(3):337-40.
2001: Marco Leuer; Johannes Oldenburg; Jean-Maurice Lavergne; M Ludwig; A Fregin; A Eigel; R Ljung; Anne C Goodeve; Ian R Peake; K Olek
Somatic mosaicism in hemophilia A: a fairly common event.
American journal of human genetics 2001;69(1):75-87.
2001: Anne C Goodeve; Ian R Peake
A standard nomenclature for von Willebrand factor gene mutations and polymorphisms.
Best practice & research. Clinical haematology 2001;14(2):235-40.
2001: Faisel M Abu-Duhier; Anne C Goodeve; Gill A Wilson; Rory S Care; Ian R Peake; John T Reilly
Genomic structure of human FLT3: implications for mutational analysis.
British journal of haematology 2001;113(4):1076-7.
2001: Faisel M Abu-Duhier; Anne C Goodeve; Gill A Wilson; Rory S Care; Ian R Peake; John T Reilly
Identification of novel FLT-3 Asp835 mutations in adult acute myeloid leukaemia.
British journal of haematology 2001;113(4):983-8.
2001: Anne C Goodeve; J C J Eikenboom; David Ginsburg; Lysiane Hilbert; Claudine Mazurier; Ian R Peake; J Evan Sadler; F Rodeghiero
A standard nomenclature for von Willebrand factor gene mutations and polymorphisms. On behalf of the ISTH SSC Subcommittee on von Willebrand factor.
Thrombosis and haemostasis 2001;85(5):929-31.
2001: S Allen; Anne C Goodeve; Ian R Peake; Martina E Daly
Endoplasmic reticulum retention and prolonged association of a von Willebrand's disease-causing von Willebrand factor variant with ERp57 and calnexin.
Biochemical and biophysical research communications 2001;280(2):448-53.
2000: Gill A Wilson; Elisabeth A Vandenberghe; R C Pollitt; David C Rees; Anne C Goodeve; Ian R Peake; John T Reilly
Are aberrant BCR--ABL transcripts more common than previously thought?
British journal of haematology 2000;111(4):1109-11.
2000: Faisel M Abu-Duhier; Anne C Goodeve; Gill A Wilson; Mamdooh A Gari; Ian R Peake; David C Rees; Elisabeth A Vandenberghe; Peter R Winship; John T Reilly
FLT3 internal tandem duplication mutations in adult acute myeloid leukaemia define a high-risk group.
British journal of haematology 2000;111(1):190-5.
2000: S Allen; AM Abuzenadah; JL Hinks; JL Blagg; T Gursel; Jørgen Ingerslev; Anne C Goodeve; Ian R Peake; Martina E Daly
A novel von Willebrand disease-causing mutation (Arg273Trp) in the von Willebrand factor propeptide that results in defective multimerization and secretion.
Blood 2000;96(2):560-8.
2000: Anne C Goodeve; I Williams; G L Bray; Ian R Peake
Relationship between factor VIII mutation type and inhibitor development in a cohort of previously untreated patients treated with recombinant factor VIII (Recombinate). Recombinate PUP Study Group.
Thrombosis and haemostasis 2000;83(6):844-8.
2000: S Allen; AM Abuzenadah; JL Blagg; JL Hinks; IM Nesbitt; Anne C Goodeve; T Gursel; Jørgen Ingerslev; Ian R Peake; Martina E Daly
Two novel type 2N von Willebrand disease-causing mutations that result in defective factor VIII binding, multimerization, and secretion of von Willebrand factor.
Blood 2000;95(6):2000-7.
1999: T C Coughlan; JL Blagg; Mansour Mohamad Saleh Abulola; Martina E Daly; KK Hampton; Michael Makris; Ian R Peake; Anne C Goodeve
Null alleles are not a common cause of type 1 von Willebrand disease in the British population.
Thrombosis and haemostasis 1999;82(4):1373-5.
1999: IM Nesbitt; KK Hampton; F Eric Preston; Ian R Peake; Anne C Goodeve
A common splice site mutation is shared by two families with different type 2N von Willebrand disease mutations.
Thrombosis and haemostasis 1999;82(3):1061-4.
1999: M Gari; Anne C Goodeve; G Wilson; P Winship; Stephen E Langabeer; David C Linch; Elisabeth A Vandenberghe; Ian R Peake; J Reilly
c-kit proto-oncogene exon 8 in-frame deletion plus insertion mutations in acute myeloid leukaemia.
British journal of haematology 1999;105(4):894-900.
1999: JL Hinks; Peter R Winship; Michael Makris; F Eric Preston; Ian R Peake; Anne C Goodeve
A rapid method for haemophilia B mutation detection using conformation sensitive gel electrophoresis.
British journal of haematology 1999;104(4):915-8.
1999: D Curtis; M Durkie; P Balac (Morris); D Sheard; Anne C Goodeve; Ian R Peake; O Quarrell; S Tanner
A study of Wilson disease mutations in Britain.
Human mutation 1999;14(4):304-11.
1998: Ajay Vora; L Frost; Anne C Goodeve; G Wilson; R M Ireland; John Lilleyman; Tim O B Eden; Ian R Peake; Sue Richards
Late relapsing childhood lymphoblastic leukemia.
Blood 1998;92(7):2334-7.
1998: Anne C Goodeve
Advances in carrier detection in haemophilia.
Haemophilia : the official journal of the World Federation of Hemophilia 1998;4(4):358-64.
1998: I J Williams; AM Abuzenadah; Peter R Winship; F Eric Preston; G Dolan; J Wright; Ian R Peake; Anne C Goodeve
Precise carrier diagnosis in families with haemophilia A: use of conformation sensitive gel electrophoresis for mutation screening and polymorphism analysis.
Thrombosis and haemostasis 1998;79(4):723-6.
1998: Anne C Goodeve
Laboratory methods for the genetic diagnosis of bleeding disorders.
Clinical and laboratory haematology 1998;20(1):3-19.
1997: L Frost; Anne C Goodeve; G Wilson; Ian R Peake; H Barker; Ajay Vora
Clonal stability in late-relapsing childhood lymphoblastic leukaemia.
British journal of haematology 1997;98(4):992-4.
1997: G Wilson; L Frost; Anne C Goodeve; Elisabeth A Vandenberghe; Ian R Peake; J Reilly
BCR-ABL transcript with an e19a2 (c3a2) junction in classical chronic myeloid leukemia.
Blood 1997;89(8):3064.
1997: Charles R M Hay; W Ollier; L Pepper; Anthony M Cumming; Steven Keeney; Anne C Goodeve; B T Colvin; Frank G H Hill; F Eric Preston; Ian R Peake
HLA class II profile: a weak determinant of factor VIII inhibitor development in severe haemophilia A. UKHCDO Inhibitor Working Party.
Thrombosis and haemostasis 1997;77(2):234-7.
1996: I M Nesbitt; Anne C Goodeve; F Eric Preston; Ian R Peake
von Willebrand factor/factor VIII binding is not affected by the Arg89Gln polymorphism in von Willebrand factor.
Thrombosis and haemostasis 1996;76(5):820-1.
1996: Anne C Goodeve; G Tagariello; Ampaiwan Chuansumrit; F Eric Preston; Ian R Peake
A rapid and cost effective method for analysis of dinucleotide repeat polymorphisms in the factor VIII gene.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1996;7(7):672-7.
1996: I M Nesbitt; Anne C Goodeve; A M Guilliatt; Michael Makris; F Eric Preston; Ian R Peake
Characterisation of type 2N von Willebrand disease using phenotypic and molecular techniques.
Thrombosis and haemostasis 1996;75(6):959-64.
1995: Stylianos Antonarakis; Judith P. Rossiter; M Young; J Horst; P de Moerloose; S S Sommer; Rhett P Ketterling; Haig Kazazian ; Claude Négrier; Christine Vinciguerra; Jane Gitschier; Michel Goossens; Emmanuelle Girodon; N Ghanem; F Plassa; Jean-Maurice Lavergne; M Vidaud; J M Costa; Yves Laurian; S W Lin; S R Lin; M C Shen; David Lillicrap; S A Taylor; S Windsor; Sophie Valleix; Khedoudja Nafa; Y Sultan; Marc Delpech; C L Vnencak-Jones; J A Phillips; R C Ljung; E Koumbarelis; AE Gialeraki; Titika Mandalaki; P Vincent Jenkins; P W Collins; K John Pasi; Anne C Goodeve; Ian R Peake; F Eric Preston; Marianne Schwartz; E Scheibel; Jørgen Ingerslev; D N Cooper; D S Millar; V V Kakkar; F Giannelli; J A Naylor; E F Tizzano; Montserrat Baiget; M Domenech; Carme Altisent; J Tusell; M Beneyto; J I Lorenzo; Christine Gaucher; Claudine Mazurier; Kathelijne Peerlinck; Gert Matthijs; J J Cassiman; J Vermylen; Pier Giorgio Mori; M Acquila; Daniela Caprino; H Inaba
Factor VIII gene inversions in severe hemophilia A: results of an international consortium study.
Blood 1995;86(6):2206-12.
1995: Ampaiwan Chuansumrit; Anne C Goodeve; Werasak Sasanakul; Ian R Peake; Pakaimas Pintadit; P Hathirat; F Eric Preston; P Isarangkul
DNA polymorphisms for carrier detection of hemophilia in Thailand.
The Southeast Asian journal of tropical medicine and public health 1995;26 Suppl 1():201-6.
1994: Anne C Goodeve; F Eric Preston; Ian R Peake
Factor VIII gene rearrangements in patients with severe haemophilia A.
Lancet 1994;343(8893):329-30.
1994: Anne C Goodeve; Ampaiwan Chuansumrit; Werasak Sasanakul; Parttraporn Isarangkura; F Eric Preston; Ian R Peake
A comparison of the allelic frequencies of ten DNA polymorphisms associated with factor VIII and factor IX genes in Thai and Western European populations.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1994;5(1):29-35.